24–25 September 2025, Tashkent, Uzbekistan
Pharma Uzbekistan & Central Asia Congress and Exhibition is a unique international platform for leaders of the pharmaceutical industry of Uzbekistan, Kazakhstan, Tajikistan and other countries of Central Asia which involves senior executives of investment projects and major pharmaceutical plants, government officials, regulators, technology licensors, developers, manufacturers and suppliers of equipment, engineering and construction companies, technology and service providers. The event is devoted to discussion of major investment projects on construction of production capacities, to efficiency boosting options of pharmaceuticals production.
Deputy Director
Pharmaceutical industry development agency Ministry of Health of the Republic of Uzbekistan
Deputy Director
Pharmaceutical industry development agency Ministry of Health of the Republic of Uzbekistan
General Director
Dentafill Plyus LLC
Deputy Sales Representative
Trade Mission of the Russian Federation to the Republic of Uzbekistan
Deputy Sales Representative
Trade Mission of the Russian Federation to the Republic of Uzbekistan
Director
GRAND PHARM LOGISTICS HUB
Head of Pharmacovigilance Department
NIKA PHARM
General Development Manager
CRPT TURON
Head of Department
Tax Committee under the Cabinet of Ministers of the Republic of Uzbekistan
Head of Department
Tax Committee under the Cabinet of Ministers of the Republic of Uzbekistan
Deputy General Director for Quality
Baxtteks-Farm
PRODUCTION OF ANALGESICS, ANTIBIOTICS, ANTIFUNGAL AND ANTIRHEUMATIC MEDICAL PREPARATIONS
Operator/initiator: Kusum Uzbekistan LLC
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: The project is developed, contractors have not been yet determined
Dates: Execution period: 2026
Investment amount: Expected project cost: 5 million US dollars
PRODUCTION OF PREPARATIONS FOR PARENTERAL NUTRITION
Operator/initiator: MASMED PHARM IMPEX LLC
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: Requires development and approval of predesign and design documentation
Dates: Feasibility study development period: Q2 2023
Execution period: 2026
Investment amount: Expected project cost: 47 million US dollars
PRODUCTION OF BLOOD PLASMABASED MEDICINAL PREPARATIONS
Operator/initiator: Haematech
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: Requires development and approval of predesign and design documentation
Dates: Feasibility study development period: Q2 2023
Realisation period: 2026
Investment amount: Expected project cost: 85 million US dollars
ESTABLISHMENT OF THE TASHKENT PHARMA PARK INNOVATIVE R&D PHARMACEUTICAL CLUSTER (PHASE 1)
Including:
– Pharmaceutical university
– Pharmacopeia centre
– R&D centre
– Expertise centre
– BSL-3 Laboratory
– Vivarium
– Experimental production lines
Operator/initiator: Agency for the Development of the Pharmaceutical Industry of the Republic of Uzbekistan
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: Construction and commissioning of the administrative buildings of the Pharmaceutical Safety Centre and Development Directorate
Dates: Phase 1 is scheduled to be commissioned in November 2027
Investment amount: 130.2 million US dollars
The project is realised in order to stimulate the comprehensive development of the pharmaceutical industry in the country, including by expanding the range of pharmaceuticals produced, conducting research and development, and training personnel in the field of pharmaceuticals qualified in accordance with international educational standards. Financing of the project is provided by preferential funds of the EDCF Fund of the Eximbank of Korea, the Fund for Reconstruction and Development of the Republic of Uzbekistan, the Fund for Support and Development of the Pharmaceutical Industry and foreign direct investment. The modular structure of the cluster with a total area of 50 hectares involves the establishment of industrial, academic, research, clinical and preclinical sectors. The cluster will host production sites of leading pharmaceutical companies producing innovative medical products, medical devices and equipment, a multi-disciplinary research university and its components, research centres, a state centre of expertise of pharmaceutical products, a data centre and other necessary infrastructure.
CONSTRUCTION OF A MANUFACTURING FACILITY FOR THE PRODUCTION OF MEDICAL PREPARATIONS IN THE PARKENT FARM FEZ
Operator/initiator: Zuma Pharm
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: Phase 1 out of 4 is completed
Dates: 2028-2033
The Company is realising the project on the construction of a manufacturing facility for the production of medical preparations in the Parkent Farm FEZ. At the moment the 1st phase is completed – the production line for biological injectable medical preparations in syringes (ready to use) and lyophilic products in vials has been launched.
Subsequent phases of realisation:
• Phase 2: production of hormonal preparations in the form of pills.
• Phase 3: release of oncological preparations in the form of injections.
• Phase 4: blood factor preparations.
Realisation timeframe: 5-10 years.
PROJECT FOR THE CONSTRUCTION OF A PLANT FOR THE PRODUCTION OF INFUSIONS AND PP AMPOULES
Operator/initiator: Dora Line
Location: Tashkent Pharma Park
Stage: Realisation
Dates: 2026
Investment amount: 16 million US dollars
Useful project plot: 1.5 ha, 9000 m2.
300+ SENIOR EXECUTIVES OF MAJOR PHARMACEUTICAL COMPANIES will discuss the main challenges and prospects.
20+ REPORTS from senior executives of key companies and industry experts containing unique information.
20+ MAJOR PROJECTS OF INDUSTRY LEADERS. The development of pharmacy in Uzbekistan and plans for the construction of new production facilities.
PHARMACY IN THE HEART OF EURASIA: A BALANCE OF CHALLENGES AND OPPORTUNITIES — public support, development of pharmaceutical clusters, strategies to attract investments.
THE FOUNDATION OF HEALTHCARE: the latest technologies in the construction and equipment of pharmaceutical production facilities.
THE FUTURE OF PHARMACEUTICAL INDUSTRY IN UZBEKISTAN: overview of key investment projects.
PRIVATE BUSINESS LUNCH OF GENERAL DIRECTORS' CLUB OF THE PHARMACEUTICAL INDUSTRY. Strictly by invitation. For more details please contact organisers.
ROUND TABLE FOR TECHNICAL MANAGERS. Lean manufacturing, process optimisation, waste minimisation, and modernisation for a sustainable future.
NEW! AWARD CEREMONY AND COCKTAIL RECEPTION. Awarding the best companies, innovative projects and outstanding experts.
TRACK & TRACE: SERIALISATION AND LABELLING OF MEDICINES.
CUSTOMIZED SOLUTIONS IN PHARMACY: transformation through personalised medicine.
WITHOUT COMPROMISE: high technology for sterile production.
IMPORTANT! GROUP DISCUSSIONS. 360° QUALITY CONTROL: from raw materials to finished products.
SPECIALIZED EXHIBITION AND TECHNOLOGICAL PRESENTATIONS. Technological presentations, roadshows, exhibitions of advanced technologies, equip-ment and services from world leaders.
2 DAYS OF BUSINESS AND INFORMAL NETWORKING! One-on-one meetings, business lunches, welcome cocktail and much more.
